Noel Jee

Partner at Novo Holdings

View Live Interactive Profile →

Biography

Noel Jee is a Partner in the Venture Investments team at Novo Holdings, based in San Francisco. He was previously an investor with Sofinnova Investments and Illumina Ventures, covering therapeutics, life science tools, diagnostics and healthcare platforms, and his time at Illumina Ventures included ten months operating a portfolio company. Before venture capital he was a management consultant at L.E.K. Consulting advising biopharma and diagnostics companies. He holds a PhD in chemistry and chemical biology from UCSF and two BS degrees, in biochemistry and in neurobiology and physiology, from the University of Maryland, College Park. Novo Holdings press releases in 2025 and 2026 describe his title as Partner, Growth Investments, which differs from the Venture Investments team assignment on his people page.

Education

Previous Experience

Notable Investments

ElektrofiRoute 92 Medical

Career Timeline

2025
Quoted as Partner, Growth Investments in Novo Holdings' announcement of the acquisition of Elektrofi by Halozyme.
2026
Named as Partner, Growth Investments in Novo Holdings' announcement of the USD 50 million growth financing in Route 92 Medical.

Sources & References

Novo Holdings - Noel Jee (people page, checked 6 September 2026) ↗Novo Holdings announces acquisition of Elektrofi by Halozyme (1 October 2025) ↗Novo Holdings leads $50 million growth financing in Route 92 Medical (7 April 2026) ↗